Ibogaine & Psychedelic Research
Knowledge Recovery Foundation Institute
Neglected Diseases Clinical Trials Research & Drug Policy Coalition
About KRFI
KRFI was launched in 1989 by MyungHi Sonserai Lee to conserve and protect indigenous knowledge of medicinal plants for the advancement of the treatment of neglected diseases around the world.
KRFI is scientifically informed practice to policy, by evidence-based research, challenge reform, to prevent overdose deaths by prevention and Opioid Use Disorder/Substance Use Disorder (OUD/SUD) dependence with the discovery, development, and delivery of Ibogaine for addiction treatments. We have been committed to the development and research of traditional plant medicines for healing applications and has developed a Drug Master File for botanical drug for Ibogaine, and aims to develop through to the clinical trial stage.
KRFI develops traditional medicines and practices by securing intellectual property and land rights for the people and lands that originally provided medicine and knowledge. Biodiversity, sustainable sourcing, intellectual property protections, and access and benefit sharing are the tenets that inform our partnerships and product development. Our Research and Educational program develop the protection of the indigenous right to IP, and medical relief, in the present cultural context of the integrative health practices of entheogenic medicine.
Grounded in Science, Technology, Health, Compassion, and Human Rights
Global Health Initiative 2030 public outreach aims to bring knowledge awareness campaign to reach the public with the purpose to collect, review, report, and publish laboratory testing results from our lab and republish data from our partnering organization's analytical data projects from worldwide.
Our goal is to bring illicit dangerous drugs' analytical report, and present safety issues of the regionally accessible drugs by individuals.Know-Drugs.us and Know-Drugs.app aims to reach individuals with practitioners, and institutions for Opioid Use Disorder/Substance Use Disorder (OUD/SUD) treatment support. The individualized interactive guidance to the practitioners and institution engaged in OUD/SUD therapies leading in diverse healing modalities with tools and Recovery and Medical Rehabilitation.
KRFI's objectives on global G20 partners to join Drug Supply Chain Security Act (DSCSA) Blockchain platform into the critical regional partnership with an in-country coordinating mechanism (CCM) level, furthering the WHO Pre-qualification to bring pharmaceutical GMP security to support action to impact regional drug policy coalition with Opiate/Opioid GMP manufacturers for QA/QC, to adapt DSCSA as the global health drug security policy adaption.
KRFI' Global Health Initiative 2030 aims to bring the partnership to the regional level through the conservation of the Indigenous rights to Access Biological Sharing (ABS). The Power of Traditional Knowledge and evidence-based research of the entheogenic medical practices of the indigenous peoples, such as the use of therapeutic Ibogaine, and medicinal plants. KRFI
demands Access for Benefit (ABS) with individuals, partners with conservation programs, and adherence to the Nagoya Protocol and the UN Convention on Biological Diversity for the indigenous people. The global psychedelic policy is needed for the entheogenic psychedelic therapeutics as an individual seeking Ibogaine and manufacturers requires to partner with the agricultural conservation programs and create applicability of the 1.5% offset funds created to fund the indigenous communities' compensation, and win back loss of land, and required for compliance by the International Trade Council for the Ibogaine. KRFI aims for ABS for Ibogaine by global NGOs partnerships.
KRFI has global clinical protocol partners with social equity research programs working to bring detox, after-care and supportive treatment of Psychedelics (Psilocybin, Medical Cannabis, and other), as entheogenic medicines for PTSD, Trauma and depression for veterans, and individuals challenged with addiction. The OUD/SUD treatments seek to develop and utilize a patient base mental health therapeutics database in conjunction to HIPPA and EHRs guidelines.
For Global Healing
KRFI was launched in 1989 by MyungHi Sonserai Lee to conserve and protect indigenous knowledge of medicinal plants for the advancement of the treatment of neglected diseases around the world.
KRFI is scientifically informed, pursue practice to policy, by evidence-based research and reform, to prevent overdose deaths by prevention and Opioid Use Disorder/Substance Use Disorder (OUD/SUD) dependence with the discovery, development, and delivery of Ibogaine for addiction treatments. We have been committed to the development and research of traditional plant medicines for healing applications and has developed a Drug Master File for botanical drug for Ibogaine, and aims to develop through to the clinical trial stage.
KRFI develops traditional medicines and practices by securing intellectual property and land rights for the people and lands that originally provided medicine and knowledge. Biodiversity, sustainable sourcing, intellectual property protections, and access and benefit sharing are the tenets that inform our partnerships and product development. Our Research and Educational program develop the protection of the indigenous right to IP, and medical relief, in the present cultural context of the integrative health practices of entheogenic medicine.
KRFI is scientifically informed with practice to policy by research and reform and aims to prevent overdose deaths by prevention and Opioid Use Disorder/Substance Use Disorder (OUD/SUD) dependence with the discovery, development, and delivery of Ibogaine for addiction treatments.
KRFI has been committed to the development and research of traditional plant medicines for healing applications and has developed a Drug Master File for botanical drug for Ibogaine, and aims to develop through to the clinical trial stage.
Join us in the unified agreements to develop a joint agreement for use of indigenous knowledge and support a sustainable model for biodiversity protection of the indigenous land for the production of the native plants. Sign the protocols with us and announce the calls on the international communities to support the indigenous communities to secure the lands and protect their cultures and medicinal plants.
Global Health Initiative 2030 public outreach aims to bring knowledge awareness campaign to reach the public with illicit drugs analytical report, regional drug accessible by individuals, Precinct and DEC alike. Know-Drugs.us and Know-Drugs.app aims to reach individuals with practitioners, institutions for Opioid Use Disorder/Substance Use Disorder (OUD/SUD) treatment support.
The individualized interactive guidance to the practitioners and institution engaged in OUD/SUD therapies leading in diverse healing modalities with tools and Medical Rehabilitation.
KRFI in collaboration with SAHMSA, aims to bring
trainings for practitioners in working with OUD/SUD locally with Clinical Treatment Applications (CTA) protocols, and training for integrated lab analysis of biomarkers through the big data management, guided protocol use of Ibogaine and psychedelic treatments.
Clinical protocol partners with social equity research programs of Psychedelics (Psilocybin, Medical Cannabis, and other), as entheogenic medicines for PTSD, Trauma and Depression for veterans, and individuals. The OUD/SUD treatments seek to develop and utilize a patient base mental health therapeutics database in conjunction to HIPPA and EHRs guidelines.
For Global Healing
KRFI Know-Drug.app is free and public benefit program to provide the public access to substance tracing through public support for analytical report information. KRFI Global Health Initiative 2030 public outreach program aims to bring knowledge awareness campaigns to inform the public about harm-reduction and support-seeking medical practitioners, personnel, and researchers. Public access to illicit drugs and their analytical report, regional drug accessible by individuals, Precinct and Department of Environmental Control (DEC) alike to be able to respond appropriately to public policies and emergency medical responses. Know-Drugs.us and Know-Drugs.App aims to reach individuals with practitioners, and institutions for OUD/SUD treatment support. Know-Drug.Org is a partnership with European partners to identify a way to reduce the harm from drug consumption by allowing users to know the content and the variety and identity of adulterants of substances around the world. The App aims to empower users to make safer choices: to avoid dangerous substances and its dangerous combinations.
Under the DSCSA Blockchain program, FDA and global compliance with regulatory requirements or an endorsement of a particular technology, system, or other approach used in the pilots reflect the diversity of the supply chain including large and small entities from all industry sectors to safeguard the future of healthcare, manufacturers in the supply chain. KRFI aims to implement Questors: DSCSA Blockchain to partner nationally, to identify and trace the Opiate, Opioid, controlled substances manufacturers globally for fake medicine and prescription drugs that are distributed illegally within the United States. DSCSA Blockchain serves as a validation program of Seeds to Products, which supports the regional Drug Policy countries joining in this global health initiative.
KRFI aims to stem the tide of opioid overdose deaths and addiction, by bringing transparency to the entire drug supply chain ecosystem.
a wellness journey.
